Zimmer Biomet Holdings IncChange company Symbol lookupSelect an option...ZBH Zimmer Biomet Holdings IncCUBE CubeSmartMRAM Everspin Technologies IncLULU Lululemon Athletica IncSSYS Stratasys LtdASTE Astec Industries IncNHTC Natural Health Trends CorpDB Deutsche Bank AGXPER Xperi Holding CorpTT Trane Technologies PLCGo
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
|
|
|
|
| |
Company Profile
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Valuation Ratios
- Price/Earnings (TTM)
- 63.72x
- Price/Sales (TTM)
- 5.08x
- Price/Book (MRQ)
- 2.89x
- Price/Cash Flow (TTM)
- 22.27x
MRQ = Most Recent Quarter
Price Performance
Financial Statements
Balance sheet
Values displayed are in millions.
Income statement
Values displayed are in millions.
Cash flow
Values displayed are in millions.
Company Officers
- Larry C. Glasscock
- Bryan C. HansonChmn.
- Suketu P. UpadhyayCFO
- Sang YiCorp.Exec.
- Ivan TornosCOO
Address
- 345 E Main St
- Warsaw, IN 46580-2746
- Phone: (574) 267-6131
- Fax: (302) 636-5454
- http://www.zimmerbiomet.com/
Insider Trading
During the most recent quarter, 31K shares were sold in insider trading.
Insider trading information report provided by Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.